Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | RAD52 | P43351 | 1/20 | 0.39 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13423666 | 1.00 | EPHX1 (0.80) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL5515259 | 1.00 | EPHX1 (0.80) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL4626384 | 1.00 | EPHX1 (0.80) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL18825665 | 1.00 | EPHX1 (0.80) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL538474 | 1.00 | EPHX1 (0.80) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL20440346 | 1.00 | EPHX1 (0.80) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL1602429 | 0.98 | EPHX1 (0.76) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| 2-(Hexadecyl)Tetrahydrofuran SCHEMBL3663252 | 0.96 | EPHX1 (0.74) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| Methoxymethane SCHEMBL28364135 | 0.94 | EPHX1 (0.71) | EPHX1ALDH1A1CYP1A2TDP1TP53 | |
| SCHEMBL28376605 | 0.94 | EPHX1 (0.71) | EPHX1ALDH1A1CYP1A2TDP1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 824 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118090939-A | Method for measuring migration quantity of ultraviolet absorber in food contact material and product | 宁波检验检疫科学技术研究院(宁波国检贸易便利化服务中心) | 2024-05-28 | — | — | CN | claimed |
| CN-112098543-B | Method for measuring contents of various perfume compounds in sole material | 深圳天祥质量技术服务有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-111032697-B | In situ polymer blends for tires | 盛禧奥欧洲有限责任公司 | 2022-07-05 | — | — | CN | claimed |
| CN-108017866-B | Polymer composition | 中国石油化工股份有限公司 | 2021-04-09 | — | — | CN | claimed |
| CN-112098543-A | Method for measuring contents of various perfume compounds in sole material | 深圳天祥质量技术服务有限公司 | 2020-12-18 | — | — | CN | claimed |
| CN-108017729-B | Monovinylarene-conjugated diene copolymer, preparation method and application thereof, composition, vulcanized rubber and vehicle tire | 中国石油化工股份有限公司 | 2020-07-24 | — | — | CN | claimed |
| US-9695164-B2 | Crystalline forms of pyrroloquinoline quinone disodium salt | ZHUCHENG HAOTIAN PHARM CO., LTD. (CN) | 2017-07-04 | — | — | US | claimed |
| US-20150291583-A1 | CRYSTALLINE FORMS OF PYRROLOQUINOLINE QUINONE DISODIUM SALT | ZHUCHENG HAOTIAN PHARM CO., LTD. (CN) | 2015-10-15 | — | — | US | claimed |
| WO-2015051141-A1 | METHODS FOR PREPARATION OF FLUORINATED SULFUR-CONTAINING COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-04-09 | — | — | WO | claimed |
| US-7485663-B2 | Carvedilol | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2009-02-03 | — | — | US | claimed |
| US-6552209-B1 | Such as reacting tantalum pentachloride with tertbutylamine and pyridine; stripping solvent and extracting into tetra-hydrofuran; adding extract to fresh in situ prepared lithium diethylamine solution; high yield and purity | AIR PRODUCTS AND CHEMICALS, INC. | 2003-04-22 | — | — | US | claimed |
| US-20020143045-A1 | Carvedilol | TEVA PHARMACEUTICALS USA, INC. | 2002-10-03 | — | — | US | claimed |
| EP-0643689-B1 | IMPROVED PROCESS FOR THE SYNTHESIS OF (5R)-1,1-DIMETHYLETHYL 6-CYANO-5-HYDROXY-3-OXO-HEXANOATE | WARNER LAMBERT CO (US) | 1998-12-30 | — | — | EP | claimed |
| EP-0763016-A1 | COMPOSITIONS AND METHODS FOR TREATING MAST-CELL MEDIATED CONDITIONS | ARRIS PHARMACEUTICAL CORPORATION (US) | 1997-03-19 | — | — | EP | claimed |
| WO-1995032945-A1 | COMPOSITIONS AND METHODS FOR TREATING MAST-CELL MEDIATED CONDITIONS | ARRIS PHARMACEUTICAL CORPORATION (US) | 1995-12-07 | — | — | WO | claimed |
| EP-0643689-A1 | IMPROVED PROCESS FOR THE SYNTHESIS OF (5R)-1,1-DIMETHYLETHYL 6-CYANO-5-HYDROXY-3-OXO-HEXANOATE | WARNER-LAMBERT COMPANY (US) | 1995-03-22 | — | — | EP | claimed |
| WO-1993007115-A1 | IMPROVED PROCESS FOR THE SYNTHESIS OF (5R)-1,1-DIMETHYLETHYL 6-CYANO-5-HYDROXY-3-OXO-HEXANOATE | WARNER-LAMBERT COMPANY (US) | 1993-04-15 | — | — | WO | claimed |
| US-5155251-A | Process for the synthesis of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate | WARNER-LAMBERT COMPANY (US) | 1992-10-13 | — | — | US | claimed |
| EP-0033402-B1 | PERFUSATE FOR PRESERVING ORGAN TO BE TRANSPLANTED AND PRESERVING METHOD | The Green Cross Corporation (JP) | 1983-09-07 | — | — | EP | claimed |
| US-3993581-A | WITH A PHOSPHOLIPID AS EMULSIFIER AND A FATTY ACID, ALKALI METAL SALT OR ITS MONOGLYCERIDE AS AN ADJUVANT | THE GREEN CROSS CORPORATION (JA) | 1976-11-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291583-A1 | CRYSTALLINE FORMS OF PYRROLOQUINOLINE QUINONE DISODIUM SALT | SFPQ, RECQL, AQP1 | EPHX1 2083/4885ALDH1A1 1085/4885CYP1A2 578/4885 |
| US-20020143045-A1 | Carvedilol | REN, ADRB1, ADRB2 | EPHX1 1262/4885ALDH1A1 1694/4885CYP1A2 160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.